Di Palma, M. et al. 2022. Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report. Mediterranean Journal of Hematology and Infectious Diseases. 14, 1 (Apr. 2022), e2022043. DOI:https://doi.org/10.4084/MJHID.2022.043.